Sort   by:  
 Page size 
UnknownTreatment free remission in chronic myeloid leukemia: Lights and shadows.
Not available
S-EPMC7520857 | biostudies-literature
UnknownELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Not available
S-EPMC9043923 | biostudies-literature
UnknownINO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Not available
S-EPMC11929536 | biostudies-literature
UnknownPegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Not available
S-EPMC10440455 | biostudies-literature
UnknownManaging chronic myeloid leukaemia in the elderly with intermittent imatinib treatment.
Not available
S-EPMC4648524 | biostudies-literature
UnknownIncidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia.
Not available
S-EPMC5685244 | biostudies-literature
Sort   by:  
 Page size